Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
UBS
Colorcon
Express Scripts
US Department of Justice
Dow
Chinese Patent Office
Deloitte
McKesson

Generated: May 21, 2018

DrugPatentWatch Database Preview

TROSPIUM CHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Trospium Chloride, and when can generic versions of Trospium Chloride launch?

Trospium Chloride is a drug marketed by Actavis Labs Fl Inc, Paddock Llc, Upsher-smith Labs, Apotex, Glenmark Generics, Heritage Pharms Inc, and Invagen Pharms. and is included in eight NDAs.

The generic ingredient in TROSPIUM CHLORIDE is trospium chloride. There are sixteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.
Drug patent expirations by year for TROSPIUM CHLORIDE
Pharmacology for TROSPIUM CHLORIDE
Synonyms for TROSPIUM CHLORIDE
(1alpha,5alpha)-3beta-[(Hydroxydiphenylacetyl)oxy]spiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]
[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate chloride
[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride
[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-oxidanyl-2,2-diphenyl-ethanoate chloride
1001323-19-8
10405-02-4
1E6682427E
2-hydroxy-2,2-diphenylacetic acid [(1S,5R)-3-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]yl] ester chloride
3-((hydroxydiphenylacetyl)oxy)-spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium chloride
3alpha-Hydroxyspiro(1alphah,5alphah-nortropane-8,1'-pyrrolidinium) benzilate
3alpha-Hydroxyspiro(1alphaH,5alphaH-nortropane-8,1'-pyrrolidinium) chloride benzilate
405T024
47608-32-2
8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride
A800884
AB0000782
AB01274814_02
AB01274814-01
AB2000646
AC-4235
AC1NR4ST
AKOS015833209
AM84314
API0004533
AS Xvii
Azoniaspiro Compound XVII
Azoniaspiro(3-alpha-benziloyloxy-nortropan-8,1'-pyrrolidine)-chloride
B-1868
BC209629
BCP0726000291
CAS-10405-02-4
CHEBI:32270
CHEMBL1888176
CHEMBL3084748
Chlorure de trospium
Chlorure de trospium [INN-French]
Cloruro de trospio
Cloruro de trospio [INN-Spanish]
CS-2572
DB00209
DSSTox_CID_3724
DSSTox_GSID_23724
DSSTox_RID_77166
DTXSID6048337
DTXSID7023724
EINECS 233-875-4
FT-0636699
HMS3656C16
HY-B0461
IP631
Keptan
MFCD00865254
MolPort-005-935-494
MolPort-046-033-481
NCGC00167438-01
NCGC00167438-02
Relaspium
RVCSYOQWLPPAOA-QKYUOBHYSA-M
s2549
Sanctura
Sanctura XR
Santura
SCHEMBL119810
SCHEMBL13836646
SCHEMBL2447242
SCHEMBL25785
Spasmex
Spasmo 3
Spasmo-lyt
Spiro (8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-((hydroxydiphenylacetyl)oxy)-, chloride, (1alpha, 3beta, 5alpha)
Spiro(1-alpha-H,5-alpha-H-nortropane-8,1'-pyrrolidinium), 3-alpha-hydroxy-, chloride, benzilate
Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium, 3-((hydroxydiphenylacetyl)oxy)-, chloride, (1alpha,3beta,5alpha)-
Spiro[8azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5);Spiro[8azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5)
ST24050330
T4Y8ORK057
Tox21_112442
Tox21_112442_1
Trospii chloridum
Trospii chloridum [INN-Latin]
Trospium
Trospium (chloride)
Trospium cation
Trospium chloride (Sanctura)
Trospium chloride [USAN:USP:INN:BAN:JAN]
Trospium Cl
Trospiumchlorid
UNII-1E6682427E
UNII-T4Y8ORK057
Uraplex
W-108827
ZINC100016084
ZINC100371992
ZINC12503068

US Patents and Regulatory Information for TROSPIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc TROSPIUM CHLORIDE trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 091289-001 Oct 12, 2012 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Invagen Pharms TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091688-001 Aug 23, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091513-001 Dec 6, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Paddock Llc TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091573-001 Nov 17, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
US Army
McKesson
Fuji
Federal Trade Commission
Express Scripts
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.